A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.
Anthony "Nino" Sireci, MD, MSc
Advertisement
Anthony “Nino” Sireci, MD, MSc, senior vice president, clinical biomarker and diagnostics development, at Eli Lilly and Company,
Articles by Anthony "Nino" Sireci, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
AI Billing, GLP-1s Among Forces Driving 9% Health Cost Spike
3
United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF
4
HDV Combo Shows No Relapses at 2 Years: Tarik Asselah, MD, PhD
5